Patent · US Active

Adenosine analogs and their use

US9255121B2 · kind B2 · utility

0Cited by
2References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 11, 2013
Grant dateFeb 9, 2016
Priority date
Expiry dateOct 11, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07H21/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided are adenosine analog compounds such asthat act as P2Y receptors, e.g., the P2Y2 receptor, including pharmaceutical compositions; and uses thereof to treat or prevent diseases associated with that receptor, e.g., disorders relating to mucus secretion, such as cystic fibrosis, chronic obstructive pulmonary disorder (COPD), asthma, constipation, chronic idiopathic constipation, dry mouth (xerostomia), gum disease, and gastrointestinal problems caused by radiation and chemotherapy for cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.